FDA Drug Safety Oversight Could Be “Transformed” By Medicare Data

FDA should develop an active surveillance system using prescription drug claims data from the Medicare population to supplement its existing drug safety system, members of the agency's Drug Safety & Risk Management Advisory Committee said May 18 and 19